Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical studyHui Yu, Hongbo Hu|Signal Transduction and Targeted Therapy|2020Cited by 2k
The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune responseZhiwen Gu, Hongbo Hu, Wenyong Yang et al.|Cellular and Molecular Immunology|2020Cited by 32
Mechanism study of ubiquitination in T cell development and autoimmune diseaseHui Yu, Liangbin Lin|Frontiers in Immunology|2024Cited by 7